Biofunctionalized liposomes to monitor rheumatoid arthritis regression stimulated by Interleukin-23 neutralization

Even after the revolution of rheumatoid arthritis (RA) treatment with biologic agents, this debilitating disease remains a major clinical problem. The outstanding outcomes of the systemic administration of antibodies (Abs) are narrowed by the risk of serious side effects and limited efficacy due to...

Full description

Bibliographic Details
Main Author: Lima, Ana Cláudia Fernandes (author)
Other Authors: Campos, Cláudia F. (author), Cunha, Cristina (author), Carvalho, Agostinho (author), Reis, R. L. (author), Ferreira, Helena Susana Costa Machado (author), Neves, N. M. (author)
Format: article
Language:eng
Published: 2021
Subjects:
Anti-IL-23 antibodies
Gold nanoparticles
IL-17A inhibition
Liposomes
Rheumatoid arthritis
17A inhibition
anti&#8208
IL&#8208
23 antibodies
Science & Technology
Online Access:https://hdl.handle.net/1822/75287
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/75287

Internet

https://hdl.handle.net/1822/75287

Similar Items